Related Experiment Videos
Beta 2-microglobulin levels in patients with renal insufficiency
S Acchiardo1, A P Kraus, B R Jennings
1Hemodialysis Unit, University of Tennessee-Memphis.
Summary
Beta 2 microglobulin (beta 2M) levels are elevated in dialysis patients. High-flux hemodialysis effectively reduces beta 2M, unlike conventional methods, highlighting membrane-dependent removal in chronic renal failure.
Area of Science:
- Nephrology
- Biochemistry
Background:
- Beta 2 microglobulin (beta 2M) is linked to amyloidosis in long-term dialysis patients.
- Elevated beta 2M levels are common in chronic renal failure.
Purpose of the Study:
- To measure beta 2M levels in patients with chronic renal failure undergoing different dialysis modalities.
- To investigate the impact of hemodialysis membranes on beta 2M removal.
Main Methods:
- Measured beta 2M levels in patients undergoing conventional hemodialysis, high-flux (HF) hemodialysis, and continuous ambulatory peritoneal dialysis (CAPD).
- Compared pre- and post-dialysis beta 2M levels.
- Assessed beta 2M levels in kidney transplant recipients.
Main Results:
- Dialysis patients exhibited markedly elevated beta 2M levels.
- Conventional hemodialysis increased beta 2M by 25.4%, while HF hemodialysis significantly decreased it by 43.0%.
- Beta 2M levels correlated with residual glomerular filtration rate (GFR) and were membrane-dependent.
Conclusions:
- High-flux hemodialysis is effective in reducing beta 2M levels in chronic renal failure patients.
- Beta 2M removal during dialysis is dependent on the membrane properties.
- Monitoring beta 2M may be valuable in managing patients with chronic kidney disease and those on dialysis.